发布求助
文献互助 智能选刊 最新文献

European Cardiology Review最新文献

筛选
英文 中文
The Evolution of Coronary Artery Spasm: How the Pendulum Has Swung 冠状动脉痉挛的演变:钟摆是如何摆动的
IF 3
European Cardiology Review Pub Date : 2023-09-01 DOI: 10.15420/ecr.2023.08
John F Beltrame, Peter Ong, Filippo Crea
{"title":"The Evolution of Coronary Artery Spasm: How the Pendulum Has Swung","authors":"John F Beltrame, Peter Ong, Filippo Crea","doi":"10.15420/ecr.2023.08","DOIUrl":"https://doi.org/10.15420/ecr.2023.08","url":null,"abstract":"","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80392174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Gaps in Modern Heart Failure and Chronic Kidney Disease Research. 现代心力衰竭和慢性肾脏疾病研究的空白。
IF 3
European Cardiology Review Pub Date : 2023-08-23 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2022.64
Simran Singh Parmar, Vasantha Muthuppalaniappan, Debasish Banerjee
{"title":"Gaps in Modern Heart Failure and Chronic Kidney Disease Research.","authors":"Simran Singh Parmar,&nbsp;Vasantha Muthuppalaniappan,&nbsp;Debasish Banerjee","doi":"10.15420/ecr.2022.64","DOIUrl":"10.15420/ecr.2022.64","url":null,"abstract":"<p><p>Heart failure and chronic kidney disease are common conditions and often coexist. Modern clinical trials are not entirely representative of heart failure patients in the community with respect to age and sex. Despite this, another group of heart failure patients, those with advanced chronic kidney disease, are even less represented in modern clinical trials. This review summarises the evidence for heart failure therapies across age, sex and severity of chronic kidney disease, and outlines the need for further research in these populations.</p>","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2023-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6e/ef/ecr-18-e51.PMC10481380.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10189106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on 'Leadless Pacemakers: Current Achievements and Future Perspectives'. 评论 "无铅起搏器：当前成就与未来展望 "发表评论。
IF 3.2
European Cardiology Review Pub Date : 2023-08-18 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2022.58
Zaki Akhtar, Manav Sohal, Mark M Gallagher
{"title":"Comment on 'Leadless Pacemakers: Current Achievements and Future Perspectives'.","authors":"Zaki Akhtar, Manav Sohal, Mark M Gallagher","doi":"10.15420/ecr.2022.58","DOIUrl":"10.15420/ecr.2022.58","url":null,"abstract":"","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8b/84/ecr-18-e50.PMC10466268.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10138080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Utility of CT Coronary Angiography in Chronic Total Occlusion Percutaneous Coronary Intervention. CT冠状动脉造影在慢性完全闭塞经皮冠状动脉介入治疗中的应用。
IF 3
European Cardiology Review Pub Date : 2023-08-18 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2022.61
Firas Yassin, Jawad Khan, Abdul Mozid, Derek Connolly, Vinoda Sharma
{"title":"The Utility of CT Coronary Angiography in Chronic Total Occlusion Percutaneous Coronary Intervention.","authors":"Firas Yassin,&nbsp;Jawad Khan,&nbsp;Abdul Mozid,&nbsp;Derek Connolly,&nbsp;Vinoda Sharma","doi":"10.15420/ecr.2022.61","DOIUrl":"10.15420/ecr.2022.61","url":null,"abstract":"<p><p>Chronic total occlusion (CTO) of the coronary arteries is a relatively common finding in routine coronary angiography. Of late, there has been considerable improvement in the success rate of percutaneous intervention for coronary CTO, attributed to technological advancement and skills development. CT coronary angiogram (CTCA) is a simple, non-invasive, and cost-effective test that aids in the diagnosis and management of coronary artery disease, including CTOs. The development of multi-slice CT and the use of 3D volume rendering images has revolutionised the diagnostic abilities of CTCA, with improvements in imaging quality and detailed anatomical and morphological characterisation of the plaque disease. In CTO percutaneous intervention, CTCA is used in pre-procedural planning, applying scoring systems to predict the likely success of the intervention as well as the post-procedural evaluation and follow-up. This review examines the different uses of CTCA in CTO intervention, its impact on successful recanalisation and the areas for future consideration.</p>","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2023-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bc/8d/ecr-18-e48.PMC10466269.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10138078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transvenous Lead Extraction: Work in Progress. 经静脉提取铅：正在进行中。
IF 3
European Cardiology Review Pub Date : 2023-06-19 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2023.06
Zaki Akhtar, Manav Sohal, Mary N Sheppard, Mark M Gallagher
{"title":"Transvenous Lead Extraction: Work in Progress.","authors":"Zaki Akhtar,&nbsp;Manav Sohal,&nbsp;Mary N Sheppard,&nbsp;Mark M Gallagher","doi":"10.15420/ecr.2023.06","DOIUrl":"10.15420/ecr.2023.06","url":null,"abstract":"<p><p>Cardiac implantable electronic devices are the cornerstone of cardiac rhythm management, with a significant number of implantations annually. A rising prevalence of cardiac implantable electronic devices coupled with widening indications for device removal has fuelled a demand for transvenous lead extraction (TLE). With advancement of tools and techniques, the safety and efficacy profile of TLE has significantly improved since its inception. Despite these advances, TLE continues to carry risk of significant complications, including a superior vena cava injury and mortality. However, innovative approaches to lead extraction, including the use of the jugular and femoral accesses, offers potential for further gains in safety and efficacy. In this review, the indications and risks of TLE are discussed while examining the evolution of this procedure from simple traction to advanced methodologies, which have contributed to a significant improvement in safety and efficacy.</p>","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2023-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c7/44/ecr-18-e44.PMC10345938.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9880460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum. 先兆子痫与心血管疾病：从妊娠到产后。
IF 3
European Cardiology Review Pub Date : 2023-06-07 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2022.56
Veronica Giorgione, Matthew Cauldwell, Basky Thilaganathan
{"title":"Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum.","authors":"Veronica Giorgione,&nbsp;Matthew Cauldwell,&nbsp;Basky Thilaganathan","doi":"10.15420/ecr.2022.56","DOIUrl":"10.15420/ecr.2022.56","url":null,"abstract":"<p><p>Hypertensive disorders of pregnancy (HDP) complicate approximately 10% of pregnancies. In addition to multiorgan manifestations related to endothelial dysfunction, HDP confers an increased risk of cardiovascular disease during delivery hospitalisation, such as heart failure, pulmonary oedema, acute MI and cerebrovascular events. However, the cardiovascular legacy of HDP extends beyond birth since these women are significantly more likely to develop cardiovascular risk factors in the immediate postnatal period and major cardiovascular disease in the long term. The main mediator of cardiovascular disease in women with a history of HDP is chronic hypertension, followed by obesity, hypercholesterolaemia and diabetes. Therefore, optimising blood pressure levels from the immediate postpartum period until the first months postnatally could have beneficial effects on the development of hypertension and improve long-term cardiovascular health. Peripartum screening based on maternal demographic, and clinical and echocardiographic data could help clinicians identify women with HDP at highest risk of developing postpartum hypertension who would benefit from targeted primary cardiovascular prevention.</p>","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2023-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b3/1c/ecr-18-e42.PMC10345941.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9880456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
When Should We Start Sodium-Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention. 我们应该在心力衰竭患者中何时开始使用钠-葡萄糖共转运蛋白抑制剂？早期干预的重要性。
IF 3
European Cardiology Review Pub Date : 2023-06-07 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2022.62
Moritake Iguchi, Hiromichi Wada, Felipe Martínez, Koji Hasegawa
{"title":"When Should We Start Sodium-Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention.","authors":"Moritake Iguchi,&nbsp;Hiromichi Wada,&nbsp;Felipe Martínez,&nbsp;Koji Hasegawa","doi":"10.15420/ecr.2022.62","DOIUrl":"10.15420/ecr.2022.62","url":null,"abstract":"www.ECRjournal.com Sodium–glucose co-transporter (SGLT2) inhibitors were primarily developed as anti-diabetic drugs to increase the excretion of glucose in the urine. However, SGLT2 inhibitors have been reported to have multifactorial effects, such as renal protection and improvement of myocardial energy metabolism and anaemia symptoms, which may exert protection against progression of heart failure beyond their mere diuretic action.","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2023-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/41/cb/ecr-18-e41.PMC10345959.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9880459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus. 2022 年欧洲心脏病学会心脏病肿瘤指南聚焦。
IF 3.2
European Cardiology Review Pub Date : 2023-04-21 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2022.63
David G Gent, Dobson Rebecca
{"title":"The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus.","authors":"David G Gent, Dobson Rebecca","doi":"10.15420/ecr.2022.63","DOIUrl":"10.15420/ecr.2022.63","url":null,"abstract":"<p><p>The expansion of the therapeutic armamentarium available to oncologists and haematologists has led to a significant improvement in cancer survival; however, many of the available treatments carry a risk of toxicity to the heart. Cardio-oncology has emerged as a rapidly developing subspeciality dedicated to improving the cardiovascular care of patients before, during and after cancer treatment. The 2022 European Society of Cardiology guidelines on cardio-oncology provide a comprehensive overview of best-practice recommendations for cardiovascular care aimed at healthcare professionals treating cancer patients. The main focus of the guidelines is to ensure patients can complete their cancer treatment without significant cardiotoxicity and the correct follow-up for the first 12 months following treatment and beyond is instituted. The guidelines provide harmonisation of baseline risk stratification and toxicity definitions and encompass recommendations for all the major classes of therapy used in modern oncology and haematology. This review summarises the key points from the guidelines document.</p>","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/32/1b/ecr-18-e16.PMC10316349.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10179307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fulminant Myocarditis: When One Size Does Not Fit All - A Critical Review of the Literature. 暴发性心肌炎：当 "一刀切 "无法解决所有问题时--文献综述。
IF 3.2
European Cardiology Review Pub Date : 2023-04-20 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2022.54
Andrea Silvio Giordani, Anna Baritussio, Cristina Vicenzetto, Maria Grazia Peloso-Cattini, Elena Pontara, Elisa Bison, Chiara Fraccaro, Cristina Basso, Sabino Iliceto, Renzo Marcolongo, Alida Linda Patrizia Caforio
{"title":"Fulminant Myocarditis: When One Size Does Not Fit All - A Critical Review of the Literature.","authors":"Andrea Silvio Giordani, Anna Baritussio, Cristina Vicenzetto, Maria Grazia Peloso-Cattini, Elena Pontara, Elisa Bison, Chiara Fraccaro, Cristina Basso, Sabino Iliceto, Renzo Marcolongo, Alida Linda Patrizia Caforio","doi":"10.15420/ecr.2022.54","DOIUrl":"10.15420/ecr.2022.54","url":null,"abstract":"<p><p>Fulminant myocarditis, rather than being a distinct form of myocarditis, is instead a peculiar clinical presentation of the disease. The definition of fulminant myocarditis has varied greatly in the last 20 years, leading to conflicting reports on prognosis and treatment strategies, mainly because of varied inclusion criteria in different studies. The main conclusion of this review is that fulminant myocarditis may be due to different histotypes and aetiologies that can be diagnosed only by endomyocardial biopsy and managed by aetiology-directed treatment. This life-threatening presentation requires rapid, targeted management both in the short term (mechanical circulatory support, inotropic and antiarrhythmic treatment and endomyocardial biopsy) and in the long term (including prolonged follow-up). Fulminant presentation has also recently been identified as a risk factor for worsened prognosis, even long after the resolution of the acute phase of myocarditis.</p>","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/51/ce/ecr-18-e15.PMC10316338.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10179312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ESC Congress 2022 Imaging Highlights. 2022 年 ESC 大会成像亮点。
IF 3.2
European Cardiology Review Pub Date : 2023-04-06 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2022.46
Valentina O Puntmann, Silvia Valbuena-López
{"title":"ESC Congress 2022 Imaging Highlights.","authors":"Valentina O Puntmann, Silvia Valbuena-López","doi":"10.15420/ecr.2022.46","DOIUrl":"10.15420/ecr.2022.46","url":null,"abstract":"<p><p>Cardiac imaging is an ever-evolving area, with imaging parameters and application in constant re-evaluation. This was reflected in many imaging debates and by the increased number of scientific contributions at the European Society of Cardiology Congress in 2022. While clinical trials tried to answer clinical questions related to the performance of different imaging modalities, many high-quality presentations focused on new imaging biomarkers in different scenarios, such as heart failure with preserved ejection fraction, valvular heart disease or long COVID. This highlights the need for the translation of cardiac imaging technology from research interests towards established measures of clinical practice.</p>","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/82/2c/ecr-18-e12.PMC10316344.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9793288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信